The Middle East and Africa kyphoplasty market was estimated at $4.1M in 2016 across the five markets (Egypt, Israel, Saudi Arabia, South Africa, and United Arab Emirates [UAE]) covered in this report. By the end of the forecast period in 2023, it is estimated that market will grow to approximately $8.2M at a Compound Annual Growth Rate (CAGR) of 10.4%.

Market for VCF repair products, including kyphoplasty balloons and kits, is a highly consolidated market. Together, three orthopedic conglomerates-DePuy Synthes, Medtronic, and Stryker-dominated the global market in 2016. These companies hold well-established orthopedic portfolios and enjoy wide-ranging distribution networks, which allow them to effectively cross-sell their VCF products. Several minor players also operate in regional markets, and domestic manufacturers of cheap copycat products are a threat in developing countries.

Key drivers of the kyphoplasty market in the forecast period are:

  • The rising prevalence of osteoporosis and osteopenia due to the increasing aging population.
  • The increasing preference for minimally invasive and outpatient procedures.

Key Topics Covered:

1. About the Authors

2. Table of Contents

3. Executive Summary

4. Introduction

5. Market Outlook

6. Market Insights

7. Competitive Assessment

  • DePuy Synthes (Johnson & Johnson)
  • Globus Medical
  • Medtronic
  • Stryker

Read more here.